Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane vs Midazolam for Upper Endoscopy Sedation
NCT04410211Completed
- Sponsor
- Universiti Malaya
- Start
- Jun 2018
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of sevoflurane in gastroesophageal reflux disease (GERD) and gastric ulcer (2 arms), sponsored by Universiti Malaya. Primary endpoints: Psychomotor recovery time at 30 minutes and Time taken to fulfil discharge criteria at 1 day. Started Jun 2018; status: completed.
02
Drugs
sevoflurane
03
Conditions
gastroesophageal reflux disease (GERD)gastric ulcer
Beyond the preview
Go deeper on NCT04410211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04410211.